Citizens Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$304K Buy
3,882
+949
+32% +$74.2K ﹤0.01% 572
2025
Q1
$213K Buy
+2,933
New +$213K ﹤0.01% 577
2023
Q3
Sell
-2,706
Closed -$255K 359
2023
Q2
$255K Sell
2,706
-3,150
-54% -$297K 0.01% 343
2023
Q1
$484K Sell
5,856
-557
-9% -$46.1K 0.02% 292
2022
Q4
$478K Sell
6,413
-2,196
-26% -$164K 0.02% 271
2022
Q3
$711K Sell
8,609
-4,055
-32% -$335K 0.03% 223
2022
Q2
$1.2M Sell
12,664
-539
-4% -$51.2K 0.05% 178
2022
Q1
$1.55M Buy
13,203
+1,357
+11% +$160K 0.05% 167
2021
Q4
$1.54M Sell
11,846
-681
-5% -$88.2K 0.05% 178
2021
Q3
$1.42M Buy
12,527
+8,219
+191% +$930K 0.05% 178
2021
Q2
$446K Sell
4,308
-4,902
-53% -$507K 0.02% 250
2021
Q1
$770K Sell
9,210
-123,263
-93% -$10.3M 0.04% 173
2020
Q4
$12.1M Sell
132,473
-2,385
-2% -$218K 0.69% 40
2020
Q3
$10.8M Buy
134,858
+2,284
+2% +$182K 0.69% 42
2020
Q2
$9.16M Sell
132,574
-2,612
-2% -$181K 0.64% 46
2020
Q1
$8.5M Sell
135,186
-8,097
-6% -$509K 0.69% 43
2019
Q4
$11.1M Sell
143,283
-7,437
-5% -$578K 0.74% 40
2019
Q3
$11M Sell
150,720
-2,601
-2% -$191K 0.8% 40
2019
Q2
$9.44M Sell
153,321
-4,812
-3% -$296K 0.69% 49
2019
Q1
$10.1M Buy
158,133
+5,721
+4% +$365K 0.74% 45
2018
Q4
$7.78M Sell
152,412
-1,665
-1% -$85K 0.71% 54
2018
Q3
$8.94M Sell
154,077
-1,041
-0.7% -$60.4K 0.71% 52
2018
Q2
$7.53M Sell
155,118
-4,023
-3% -$195K 0.63% 57
2018
Q1
$7.4M Buy
+159,141
New +$7.4M 0.62% 59